Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
出版年份 2022 全文链接
标题
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
作者
关键词
-
出版物
Nature Communications
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-07
DOI
10.1038/s41467-022-33599-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Small-cell lung cancer
- (2021) Charles M. Rudin et al. Nature Reviews Disease Primers
- A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
- (2021) Allison August et al. NATURE MEDICINE
- Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
- (2020) Lidia Franco-Luzón et al. Oncotarget
- Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
- (2020) Selene Ottonello et al. Frontiers in Immunology
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- Oncolytic Viruses and the Immune System: The Dynamic Duo
- (2020) Ana Lemos de Matos et al. Molecular Therapy-Methods & Clinical Development
- ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
- (2020) Brian B Haines et al. Cancer Immunology Research
- Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo
- (2019) Yalong Wang et al. MOLECULAR PHARMACEUTICS
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
- (2019) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- Oncolytic viruses: overcoming translational challenges
- (2019) Jordi Martinez-Quintanilla et al. JOURNAL OF CLINICAL INVESTIGATION
- Developing Picornaviruses for Cancer Therapy
- (2019) McCarthy et al. Cancers
- Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21
- (2019) Nicola E Annels et al. CLINICAL CANCER RESEARCH
- A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
- (2019) Nurgun Kose et al. Science Immunology
- Intratumoral Immunotherapy—Update 2019
- (2019) Omid Hamid et al. ONCOLOGIST
- A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
- (2019) Erin L. Schenk et al. Journal of Thoracic Oncology
- Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
- (2019) Yuhua Weng et al. Molecular Therapy-Nucleic Acids
- Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
- (2019) Meijun Zheng et al. Molecular Therapy-Oncolytics
- HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
- (2018) Laura Menotti et al. Viruses-Basel
- Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
- (2018) Benjamin J. Drapkin et al. Cancer Discovery
- Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy
- (2018) Robert A. Berkeley et al. Cancer Immunology Research
- Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1
- (2018) Lin Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome wide analysis of the evolution of Senecavirus A from swine clinical material and assembly yard environmental samples
- (2017) Wanhong Xu et al. PLoS One
- Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics
- (2017) Jennifer L. Marlowe et al. Nucleic Acid Therapeutics
- Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
- (2017) Katsuyuki Aoyama et al. Scientific Reports
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymeric oncolytic adenovirus for cancer gene therapy
- (2015) Joung-Woo Choi et al. JOURNAL OF CONTROLLED RELEASE
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma
- (2015) Peng-Peng Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
- (2013) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
- (2009) Radharani Gollamudi et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
- (2009) Marc T Abrams et al. MOLECULAR THERAPY
- Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus
- (2008) L. M. Hales et al. JOURNAL OF GENERAL VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started